Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0012 USD
Change Today 0.00 / 0.00%
Volume 50.3K
TNGNQ On Other Exchanges
As of 8:10 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

tengion inc (TNGNQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/25/14 - $0.20
52 Week Low
12/31/14 - $0.0008
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TENGION INC (TNGNQ)

Related News

No related news articles were found.

tengion inc (TNGNQ) Related Businessweek News

No Related Businessweek News Found

tengion inc (TNGNQ) Details

Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which is in Phase I clinical trial and used to replace the use of bowel tissue in bladder cancer patients requiring a non-continent urinary diversion after bladder removal surgery. The company has a license agreement with Children’s Medical Center Corporation (CMCC) for the license of certain patent rights and intellectual property rights owned or controlled by CMCC related to tissue engineering technology. Tengion, Inc. was founded in 2003 and is headquartered in Winston-Salem, North Carolina. On December 29, 2014, Tengion, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

25 Employees
Last Reported Date: 04/9/14
Founded in 2003

tengion inc (TNGNQ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $462.4K
Chief Scientific Officer and President of Res...
Total Annual Compensation: $380.8K
Compensation as of Fiscal Year 2013.

tengion inc (TNGNQ) Key Developments

Tengion, Inc. will Change its Ticker to TNGNQ from TNGN

Effective December 31, 2014, Tengion, Inc. will change its Pink Sheets LLC stock ticker symbol to TNGNQ from TNGN.

Tengion, Inc. Proposes Amendment to the Fourth Amended and Restated Certificate of Incorporation

Tengion, Inc. announced that at the special meeting of shareholders to be held on December 22, 2014, the company will propose to approve amendment to the fourth amended and restated certificate of incorporation, as amended to increase the number of authorized shares of common stock from 10,000,000,000 to 20,000,000,000 shares.

Tengion, Inc., Special/Extraordinary Shareholders Meeting, Dec 22, 2014

Tengion, Inc., Special/Extraordinary Shareholders Meeting, Dec 22, 2014., at 09:00 US Eastern Standard Time. Location: Royer Cooper Cohen Braunfeld LLC. Agenda: To consider and approve an amendment to the fourth amended and restated certificate of incorporation, as amended to increase the number of authorized shares of common stock from 10,000,000,000 to 20,000,000,000 shares; and to transact such other business as may properly come before the special meeting or any adjournment or adjournments thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNGNQ:US $0.00 USD 0.00

TNGNQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TNGNQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation TNGNQ Industry Range
No financial data is available for TNGNQ.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TENGION INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at